From The Editor

  1. Designing eCOA Technology Patients Can Actually Use 7/15/2026

    Why eCOA usability problems start upstream in trial design and workflow, not inside the app itself.

  2. Clinical Trial Technology Doesn't Fail – It Fails At The Handoff 7/15/2026

    Why clinical trial technology breaks down at sponsor-CRO-site handoffs, not inside any single system.

  3. Inside Versiti's Data Strategy: Building AI-Ready Research Systems 7/10/2026

    Versiti’s Banu Santebennur explains how clean data, semantic layers, and cautious tech adoption prepare clinical research for AI.

  4. How Versiti Turns Data Into A Lifeline For Rare Blood Patients 7/10/2026

    Versiti’s blood, diagnostic, and research teams show how a nonprofit uses technology to connect donors to the patients who need them most.

  5. Building A Clinical Trial Tech Stack That Actually Works 6/9/2026

    The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.

  6. The Integration Dilemma: Who Decides Which Tech Stack Wins? 6/9/2026

    Sponsors and sites both have technology, but integration only works when validation, economics, and site diversity are factored in from the start.

  7. Why Clinical Trial Sites Are Drowning In Tech Chaos 6/9/2026

    Sites aren’t resistant to technology; they’re buried under disconnected systems, delayed documents, and manual workarounds sponsors keep ignoring.

  8. The Risks And Unresolved Rules Of Real-Time Clinical Trials 5/26/2026

    RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.

  9. What Real-Time Clinical Trials Demand From Your Tech Stack 5/26/2026

    RTCT requires continuous data flow, AI governance, and real-time coordination. Here’s what the infrastructure shift actually demands, and where the current industry falls short.

  10. The FDA's RTCT Push: What It Is; Why It Matters 5/20/2026

    The FDA launched real-time clinical trials with AstraZeneca and Amgen. Here’s what RTCT is, why it matters, and what it actually demands from the clinical research ecosystem.